Adverse effects of chronic low level lead exposure on kidney function--a risk group study in children.
BACKGROUND
Children have been considered a risk group for lead (Pb) toxicity, mainly because of neurophysiological or neuro-cognitive deficits following Pb exposure. Blood Pb levels (b-Pb) of 100 microg/l currently have been defined as the lowest adverse effect level. The aim of this study was to compare, with the help of urinary markers, the kidney function of children with b-Pb just above this threshold with that of unexposed children, to assess from a nephrological point of view whether the current threshold is justified and whether children really are a particularly vulnerable risk group in terms of Pb-induced kidney damage.


METHODS
In a cross-sectional study, 112 children, either from unexposed areas (controls, n=50) or Pb-contaminated areas (n=62), the latter partly with a known history of elevated b-Pb, were examined. Twenty nine urinary or serum markers mostly related to the function or integrity of specific nephron segments were determined (e.g. filtered plasma proteins, tubular enzymes, tubular antigens, eicosanoids).


RESULTS
b-Pb were 39+/-13 microg/l in controls and 133+/-62 microg/l in exposed children. The main findings were increased excretion rates of prostaglandins and thromboxane B2, epidermal growth factor, beta2-microglobulin and Clara cell protein in the exposed children. A relationship between b-Pb and the prevalence of values above the upper reference limits was observed.


CONCLUSIONS
With the help of urinary markers, nephron segment-specific effects of chronic low-level Pb exposure could be detected in children. The pattern of effects on glomerular, proximal and distal tubular and interstitial markers was similar to that previously observed in adults. The changes, however, occur at lower b-Pb levels than in adults. The current threshold appears to be justified also from a nephrological point of view, and children can indeed be considered a special risk group.
Division of Nephrology, Medical School Hannover, Germany.
L M
LM
Fels
M
M
Wünsch
J
J
Baranowski
I
I
Norska-Borówka
R G
RG
Price
S A
SA
Taylor
S
S
Patel
M
M
De Broe
M M
MM
Elsevier
R
R
Lauwerys
H
H
Roels
A
A
Bernard
A
A
Mutti
E
E
Gelpi
J
J
Roselló
H
H
Stolte
D015415:Biomarkers; D001769:Blood / Q000378:metabolism; D002648:Child; D003430:Cross-Sectional Studies; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D007686:Kidney Tubules, Distal / Q000503:physiopathology; D007687:Kidney Tubules, Proximal / Q000503:physiopathology; D007854:Lead / Q000009:adverse effects*; D008297:Male; D012307:Risk Factors; D013997:Time Factors; D014556:Urine / Q000737:chemistry
D015415:Biomarkers; D007854:Lead